Analystreport

Ocular Therapeutix, Inc. (NASDAQ: OCUL) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $17.00 price target on

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com